Biophysical investigation on left ventricular myocytes in rats with experimentally induced diabetes

Physiological Research

Volumn 59, Issue SUPPL.1, 2010, Pages 9-17

  Waczulikova I ^a   Cagalinec, M ^b   Ulicna O ^c   Slezak P ^d   Ziegelhoffer A ^d  

^a Physics and Informatics   (Slovakia)

^b UNIVERSITY OF TARTU   (Estonia)

^c Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^d INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Biophysical properties; Fluorescence spectroscopy and microscopy; Left ventricular myocytes; Membranes; Mitochondria

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; CALCIUM SIGNALING; CELL MEMBRANE POTENTIAL; CELL SIZE; ENERGY METABOLISM; EXPERIMENTAL DIABETES MELLITUS; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART VENTRICLE; MEMBRANE FLUIDITY; METABOLISM; MITOCHONDRIAL MEMBRANE; PATHOPHYSIOLOGY; RAT; REVIEW; SARCOLEMMA;

ANIMALS; CALCIUM SIGNALING; CELL SIZE; DIABETES MELLITUS, EXPERIMENTAL; ENERGY METABOLISM; HEART VENTRICLES; MEMBRANE FLUIDITY; MEMBRANE POTENTIALS; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANES; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; RATS; SARCOLEMMA;

EID: 77956630632     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. AHMED N: Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res Clin Pr 67: 3-21, 2005.
2. BARENHOLZ Y, COHEN T, HAAS E, OTTOLENGHI M: Lateral organization of pyrene-labeled lipids in bilayers as determined from the deviation from equilibrium between pyrene monomers and excimers. J Biol Chem 271: 3085-3090, 1996.
3. BAYNES JW, THORPE SR: Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9, 1999.
4. BROWNLEE M: The pathological implications of protein glycation. Clin Invest Med 18: 275-281, 1995.
5. CAGALINEC M, KYSELOVIC J, BLASKOVA E, BACHAROVA L, CHORVAT D Jr, CHORVATOVA A: Comparative study of the effects of lacidipine and enalapril on the left ventricular cardiomyocyte remodeling in spontaneously hypertensive rats. J Cardiovasc Pharmacol 47: 561-570, 2006.
6. DOBACZEWSKI M, KAZMIERCZAK P, RAVINGEROVÁ T, ULIČNÁ O, NOCUN M, WACZULÍKOVÁ I, MARKUSZEWSKI L, WATALA C: Ex vivo detection of rat coronary endothelial dysfunction in diabetes mellitus: Methodological considerations. Methods Find Exp Clin Pharmacol 28: 507-513, 2006.
7. FERDINANDY P, SZILVASSY Z, BAXTER GF: Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? Trends Pharmacol Sci 19: 223-229, 1998
8. FERKO M, HABODÁSZOVÁ D, WACZULÍKOVÁ I, MUJKOSOVÁ J, KUCHARSKÁ J, SIKUROVÁ L, ZIEGELHOFFER B, STYK J, ZIEGELHOFFER A: Endogenous protective mechanisms in remodeling of rat heart mitochondrial membranes in the acute phase of streptozotocin-induced diabetes. Physiol Res 57: 67-73, 2008.
9. GENNIS RB: Biomembranes. Molecular Structure and Function. CR CANTOR (ed.), Springer-Verlag, New York, 1989, 533 pp.
10. KASS M, WITKIN A, TERZOPOULOS D: Snakes: active contour models. Int J Comput Vision 1: 321-331, 1988.
11. PIERCE GN, DHALLA NS: Heart mitochondrial function in chronic experimental diabetes in rats. Can J Cardiol 1: 48-54, 1985.
12. PIERCE GN, NAGANO M, ZAHRADKA P, DHALLA NS (eds.), Atherosclerosis, Hypertension and Diabetes. Kluwer Academic Publishers, Norwell, MA, USA, 2003, 520 pp.
13. RAVINGEROVA T, PANCZA D, VOLKOVOVA K, DZURBA A, STETKA R, ZIEGELHÖFFER A, STYK J: Response to myocardial ischemia is modulated in diabetic rat heart: adaptation to disease? Exp Clin Cardiol 3: 122-128, 2000
14. ROUSLIN W, MILLARD RW: Canine myocardial ischemia: defect in mitochondrial electron transfer complex I. J Mol Cell Cardiol 12: 639-645, 1980.
15. SHINITZKY M: Membrane Fluidity and Cellular Functions. Physiology of Membrane Fluidity. M. SHINITZKY (ed.), CRC Press, Boca Raton, 1984, pp 1-184.
16. SLEZÁK P, ŠIKUROVÁ L: Influence of storage of insulated erythrocytes membranes on membrane. In: Proceedings of the 3rd Slovak Biophysical Symposium, Bratislava, 2008, pp 65-66.
17. TRETTER L, ADAM-VIZI V: Mechanisms for endogenous production and elimination of reactive oxygen species in mitochondria. EJB, The FEBS J 271 (Suppl. I): 198, 2004.
18. ULIČNÁ O, ZLATOŠ L, HOLZEROVÁ J, KVASZOVÁ E, ČÁRSKY J, GVOZDJAKOVÁ A, KUCHARSKÁ J, BADA V: The effect of neonatally induced streptozotocine diabetes on hepatic mitochondrial bioenergetics in adult rats. Bratisl Lek Listy 100: 5-11, 1999.
19. VOZÁR J, KREZE A, KLIMEŠ I. (eds.), Diabetes Mellitus. Slovak Academic Press, Bratislava, 1998, pp 1-286.
20. WACZULÍKOVÁ I, ŠIKUROVÁ L, BRYSZEWSKA M, REKAWIECKA K, ČÁRSKY J, ULIČNÁ O: Impaired erythrocyte transmembrane potential in diabetes mellitus and its possible improvement by resorcylidene aminoguanidine. Bioelectrochemistry 52: 251-256, 2000.
21. 2+ overload. J Physiol Pharmacol 53: 727-739, 2002.
22. WACZULÍKOVÁ I, HABODASZOVÁ D, CAGALINEC M, FERKO M, ULIČNÁ O, MATEAŠIK A, ŠIKUROVÁ L, ZIEGELHÖFFER A: Mitochondrial membrane fluidity, potential, and calcium transients in the myocardium from acute diabetic rats. Can J Physiol Pharmacol 85: 372-381, 2007.
23. WACZULÍKOVÁ I, KINCELOVÁ D, CAGALINEC M, ULIČNÁ O, FERKO M, MUJKOŠOVÁ J, RAVINGEROVÁ T, ZIEGELHÖFFER A, ŠIKUROVÁ L: Biophysical methodology helps to provide insight into the changes in heart caused by streptozotocin-induced diabetes and hypertension. In: Experimental Approaches in Basic Research and Diagnostic of Diseases: Tailoring the Treatment. N TRIBULOVÁ, Ľ OKRUHLICOVÁ, J SLEZÁK (eds), VEDA, Bratislava, 2008, pp 91-103.
24. WACZULÍKOVÁ I, SLEZÁK P: Statistics in Medical Research. Radiology IV: Uroradiology (in Slovak). Veda, Bratislava, 2009. ISBN 978-80-224-1102-8.
25. WATALA C: Altered structural and dynamic properties of blood cell membranes in diabetes mellitus. Diabetic Med 10: 13-20, 1993.
26. WATALA C, WACZULÍKOVÁ I, WIECLAWSKA B, ROZALSKI M, GREŠNER P, GWOŹDZIŃSKI K, MATEAŠIK A, ŠIKUROVÁ L: Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets. Cytometry 49: 119-123, 2002.
27. ZIEGELHÖFFER A, WACZULÍKOVÁ I, RAVINGEROVÁ T, ZIEGELHÖFFER-MIHALOVIČOVÁ B, NECKÁŘ J, STYK J: Augmented energy transfer in rat heart mitochondria: compensatory response to abnormal household of energy in acute diabetes. In: Atherosclerosis, Hypertension and Diabetes. GN PIERCE, M NAGANO, P ZAHRADKA, NS DHALLA, KLUWER (eds), Academic Publishers, Boston, 2003, pp 439-453.
28. ZIEGELHÖFFER A: Endogenous protective mechanisms in the heart triggered by acute streptozotocin-diabetes. In: Experimental Hypertension and Ischemic Heart Disease. L BACHÁROVÁ, J KYSELOVIČ, J SLEZÁK, (eds), VEDA, Publishing House of the Slovak Academy of Sciences, Bratislava, 2005, pp 193-208.
29. ZIEGELHÖFFER A, WACZULÍKOVÁ I, FERKO M, KINCELOVÁ D, ZIEGELHÖFFER B, RAVINGEROVÁ T, CAGALINEC M, SCHÖNBURG M, ZIEGELHÖFFER T, ŠIKUROVÁ L, ULIČNÁ O, MUJKOŠOVÁ J: Calcium signaling-mediated endogenous protection of cell energetics in the acutely diabetic myocardium. Can J Physiol Pharmacol 87: 1083-1094, 2009.
30. ZIEGELHÖFFER-MIHALOVIČOVÁ B, OKRUHLICOVÁ Ľ, TRIBULOVÁ N, RAVINGEROVÁ T, VOLKOVOVÁ K, ŠEBOKOVÁ J, ZIEGELHÖFFER A: Mitochondrial contact sites detected by creatine phosphokinase activity in the hearts of normal and diabetic rats: Is the contact sites formation a calciumdependent process? Gen Physiol Biophys 16: 329-338, 1997
31. ZIEGELHÖFFER-MIHALOVIČOVÁ B, WACZULÍKOVÁ I, ŠIKUROVÁ L, STYK J, ČÁRSKY J, ZIEGELHÖFFER A: Remodeling of the sarcolemma in diabetic rat hearts: The role of membrane fluidity. Mol Cell Biochem 249: 175-182, 2003.
32. ZVARÍK M, ŠIKUROVÁ L: Monitoring possibilities of the mitochondrial membrane potential by a thiadicarbocyanine tribromide fluroscent probe. In: Proceedings of the 3rd Slovak Biophysical Symposium. Bratislava, 2008, pp 51-52.